Screener
Celldex Therapeutics CLDX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$73.5M-29.9% | -$78.69M-46.3% | -$81.32M-72.7% | -$67.04M-59.2% | -$56.6M-57.9% | ||
| $902K+3.3% | $854K-1.5% | $816K-0.4% | $824K+4.8% | $873K+9.5% | ||
| $8.41M-8.5% | $8.52M-8.5% | $8.91M-8.9% | $8.8M-8.5% | $9.19M+20.3% | ||
| -$57.41M-30.5% | -$65.59M-20.6% | -$63.94M-96.9% | -$48.63M+12.1% | -$44.01M-50.0% | ||
| $3.18M+337% | $1.64M+518% | $1.28M+69.4% | $440K-19.3% | $728K+166% | ||
| -$255.52M-613% | $72.12M+67.9% | $55.43M— | $60.85M— | $49.85M+207% | ||
| $324.66M+515,229% | $327K+61.9% | $1.35M+249% | $774K-37.5% | $63K-98.3% | ||
| $11.73M— | $6.86M+161% | —— | $12.99M— | —— | ||
| -$60.59M-35.4% | -$67.23M-23.0% | -$65.22M-96.3% | -$49.07M+12.2% | -$44.73M-51.1% |
FAQ
- How much cash does Celldex Therapeutics generate?
- Celldex Therapeutics (CLDX) generated -$235.6M in operating cash flow over the trailing twelve months.
- What is Celldex Therapeutics's free cash flow?
- After $6.5M of capital expenditures, Celldex Therapeutics's free cash flow was -$242.1M over the trailing twelve months, down 28.4% year over year.
- Where does Celldex Therapeutics's cash flow data come from?
- Every line is extracted from Celldex Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
